BBA
CINC

Baker Bros. Advisors’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Baker Bros. Advisors’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-807,212
Closed -$9.92M – 117
2022
Q4 		$9.92M Hold
807,212
– – 0.06% 58
2022
Q3 		$26.5M Buy
+807,212
New +$22.8M 0.17% 38

Baker Bros. Advisors's CINC Position: Q1 2023 in Review

Baker Bros. Advisors sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 807,212 shares — an estimated $9.92M sold.

Baker Bros. Advisors first reported a position in CINC in Q3 2022 and held it in 2 quarters. The position peaked at $26.5M in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • Baker Bros. Advisors reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Baker Bros. Advisors sold 807,212 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $9.92M.
  • Baker Bros. Advisors first reported a position in CinCor Pharma, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Baker Bros. Advisors's CinCor Pharma, Inc. Common Stock position peaked at $26.5M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Baker Bros. Advisors's 13F filing for Q1 2023, filed 15 May 2023.